Andreas Mades

680 citations
6 papers · 528 · 1 hit paper · h-index 5

Impact in

  • Oncology top 5%
    • CAR-T cell therapy research
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 5
    • Viral Infectious Diseases and Gene Expression in Insects 1
    • RNA regulation and disease 1

Andreas Mades

6 papers receiving 524 citations

Andreas Mades's Hit Papers

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells 2019 · 388 citations
3880+2+4Years since publication100200300

Peers

Andreas Mades
Comparison fields: 5 of 41
  • Oncology 433
  • Immunology 137
  • Genetics 145
  • Biomedical Engineering 165
  • Molecular Biology 169
Replace Silke Frenz with:
Silke Frenz Germany
Katrin Mestermann Germany
Claudia Geldres United States
Simon Loff Germany
Ian R. Hardy United States
Malgorzata Olszewska United States
Alexandra Kegler Germany
Mohamed-Reda Benmebarek Germany
Rama Shivakumar United States
Jolanta Stefanski United States
Andreas Mades relative to Silke Frenz Germany Silke Frenz's profile →
Citations per field
00.5×1.5×
Silke Frenz · 1×
Citations per year

Countries citing papers authored by Andreas Mades

Since Specialization
Citations

This map shows the geographic impact of Andreas Mades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Mades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Mades more than expected).

Fields of papers citing papers by Andreas Mades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Mades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Mades. The network helps show where Andreas Mades may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Mades, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Mades Line = papers co-authored together Andreas Mades links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Hit paper breakdown →
2019388
2 201966
3 201852
4 201213
5 20158
6 20181

About Andreas Mades

Andreas Mades is a scholar working on Oncology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 6 papers that have together received 528 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (3 papers), Cell Adhesion Molecules Research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Oncology (433 citations), Immunology (137 citations), Genetics (145 citations), Biomedical Engineering (165 citations) and Molecular Biology (169 citations). Andreas Mades has collaborated with scholars based in Germany and United States. Frequent co-authors include Michael Hudecek, Hermann Einsele, Silke Frenz, Julian Rydzek, Katrin Mestermann, Justus Weber, Thomas Nerreter, Michel Sadelain, Theodoros Giavridis and Christoph Rader. Their work appears in journals such as Blood, International Journal of Cancer, Nature Biotechnology, Science Translational Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact